Publication Leprosy post-exposure prophylaxis risks not adequately assessed – Author's reply Richardus JH, Mieras L, Saunderson P, et al. Elsevier BV. The Lancet Global Health. 2021; 9 (4) : e402-e403. Download PDF
Publication Number of people requiring post-exposure prophylaxis to end leprosy: A modeling study. Taal A, Blok D, van Brakel WH, et al. PLoS neglected tropical diseases. 2021; 15 (2) : e0009146. Download PDF
Publication A single dose of rifampicin to prevent leprosy; quantitative analysis of impact on perception, attitudes and behaviour of persons affected, contacts and community members towards leprosy in India, Nepal and Indonesia Mieras L, Singh MK, Manglani P R, et al. Leprosy Review. 2020; 91 (4) : 314-327. Download PDF
Publication Leprosy - the current target in national programmes. Thangaraju P, Venkatesan N, Siddarth S, et al. Journal of family medicine and primary care. 2020; 9 (10) : 5409-5410. Download PDF
Publication Leprosy post-exposure prophylaxis: innovation and precision public health. Moraes M, Duppre NC. The Lancet. Global health. 2021; 9 (1) : e8-e9. Download PDF
Publication Interim Advice on the use of Rifampicin for post-exposure prophylaxis (PEP), in light of recent information on nitrosamine impurities in rifampicin ILEP Technical Commission . 2021; Download PDF
Publication Global consultation of National Leprosy Programme managers, partners and affected persons on Global Leprosy Strategy 2021–2030: Report of the virtual meeting 26-30 October 2020 WHO/Department of control of neglected tropical diseases . World Health Organization. 2020; Download PDF
Publication Leprosy/Hansen disease: Contact tracing and post-exposure prophylaxis World Health Organization . World Health Organization. 2020; Download PDF
Publication Accelerating towards a Leprosy Free India through innovative approaches in the National Leprosy Eradication Programme (NLEP), India Kumar A, Karotia D. Lepra. Leprosy review. 2020; 91 (2) : 145-154. Download PDF
